GIS vs SMMT · P/E 8.2, rev $18.42B vs $11.46B cap
General Mills Inc (GIS) versus Summit Therapeutics PLC (SMMT) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
SMMT does not have a complete income-statement cache yet.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. SMMT currently screens at market cap $11.46B.
Not investment advice. Open the GIS and SMMT stock pages for the full models.
Not investment advice.